Pharmafile Logo
Pharmafocus logo
Advanced Search
CT scan

Merck and Pfizer kick off Phase III avelumab cancer trials

December 23, 2015
Research and Development Merck, Pfizer, avelumab, ovarian cancer

Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …

News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015
Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …

News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015
Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …

News
Gilenya

EMA adds warning label to Novartis’ MS treatment Gilenya

December 22, 2015
Manufacturing and Production EMA, European Medicines Agency, FDA, Novartis, PML, basal cell carcinoma, fingolimod, gilenya

Drug safety regulators in Europe have said they will add warnings to the label and prescribing information of Gilenya (fingolimod), …

News
ABPI

Pharma industry will pay £550m of NHS 2016 drugs bill

December 22, 2015
Manufacturing and Production ABPI, PPRS, Pharmaceutical Price Regulation Scheme

A new financial agreement announced this week as part of the Pharmaceutical Price Regulation Scheme (PPRS), will see the pharmaceutical …

News
Sun Pharma logo

Sun Pharma hit by FDA inspection warning

December 22, 2015
Manufacturing and Production FDA, Sun Pharma, manufacturing, production

Sun Pharma shares fell some 7% early this week after it emerged the Indian company received a warning letter from …

News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …

Appointment
cdic_bangladesh_dhaka_day_12

Two billion people still lack medicines access. Is the industry doing enough?

December 22, 2015
Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing

“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …

Feature
sir_kent_woods

EMA management board chair stands down

December 21, 2015
Manufacturing and Production, Sales and Marketing EMA, European Medicines Agency, Sir Kent Woods

Sir Kent Woods will step down as chair of the board at the EMA from the end of December 2015. …

Appointment
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015
Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

News

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …

News
Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015
Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …

News
Ionis logo

ISIS Pharma changes name to Ionis to avoid ‘distracting’ militant association

December 21, 2015
Sales and Marketing Ionis, Isis Pharmaceuticals, branding, marketing, rebrand

After months of discussion, ISIS Pharmaceuticals has changed its name to Ionis to free itself from the fear of confusion …

News
580x381_merck_opens_its_office_in_nigeria_3_tcm2432_145041

Merck on the march in Africa

December 21, 2015
Sales and Marketing Africa, Merck, marketing, sales, strategy

When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …

Feature
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015
Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …

News
shkreli_thumb

Martin Shkreli resigns from Turing

December 21, 2015
Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals

Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …

Appointment
paris_alternate_high-res_web

Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec

December 21, 2015
Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger

The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …

Appointment
Gilead sign

Gilead steps in to rescue Galapagos RA drug

December 18, 2015
Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis

Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …

News
Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015
Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …

News
shkreli_youtube_screenshot

Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man

December 18, 2015
Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals

As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …

Feature
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026